Broman Aimee Teo, Quigley Harry A, West Sheila K, Katz Joanne, Munoz Beatriz, Bandeen-Roche Karen, Tielsch James M, Friedman David S, Crowston Jonathan, Taylor Hugh R, Varma Rohit, Leske M Cristina, Bengtsson Boel, Heijl Anders, He Mingguang, Foster Paul J
Dana Center for Preventive Ophthalmology and the Glaucoma Service, Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Invest Ophthalmol Vis Sci. 2008 Jan;49(1):66-76. doi: 10.1167/iovs.07-0866.
To estimate the rate of visual field progression in open-angle glaucoma (OAG) subjects, by using data from population-based cross-sectional studies.
Subjects with OAG were identified in nine surveys of randomly sampled populations using standard criteria for glaucomatous optic neuropathy. Subjects were of European, African, Chinese, and Hispanic ethnicity. The measure of OAG damage was the mean deviation (MD) of an automated visual field test (Humphrey Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA). The rate of progression was the mean of all subjects' damage in the worse eye divided by an average time since onset. Time since onset was estimated from age-specific prevalence rates.
A total of 1066 subjects with OAG contributed visual field data. The mean worsening in decibels per year was: European-derived, -1.12; Hispanic, -1.26; African-derived, -1.33; and Chinese -1.56 (difference among ethnicities, P = 0.16). The mean duration of disease was lowest among Chinese persons at 10.5 years (95% CI: 8.8-12.6) and was highest in African-derived subjects at 15.4 years (95% CI: 14.6-15.9). The progression rate was not consistently related to age or gender. By combining disease duration and progression rate, the model predicted that 15% or fewer of the worse eyes would reach the end of the field damage scale in the patient's lifetime.
The estimates of typical worsening per year in the worse eye among subjects with OAG suggested slightly more rapid progression than in some clinic-based studies. The rate did not differ significantly by ethnicity or gender, but was worse in those with known, treated OAG and in pseudophakic subjects.
通过基于人群的横断面研究数据,评估开角型青光眼(OAG)患者的视野进展率。
采用青光眼性视神经病变的标准标准,在九项随机抽样人群调查中确定OAG患者。受试者包括欧洲、非洲、中国和西班牙裔种族。OAG损伤的测量指标是自动视野测试(Humphrey视野分析仪;卡尔蔡司医疗技术公司,加利福尼亚州都柏林)的平均偏差(MD)。进展率是所有受试者较差眼中损伤的平均值除以发病以来的平均时间。发病以来的时间根据特定年龄患病率估算。
共有1066例OAG患者提供了视野数据。每年平均恶化的分贝数为:欧洲裔,-1.12;西班牙裔,-1.26;非洲裔,-1.33;华裔,-1.56(种族间差异,P = 0.16)。疾病的平均持续时间在华裔中最短,为10.5年(95%可信区间:8.8 - 12.6),在非洲裔受试者中最长,为15.4年(95%可信区间:14.6 - 15.9)。进展率与年龄或性别无一致关联。通过结合疾病持续时间和进展率,该模型预测,在患者一生中,较差眼中15%或更少的眼睛将达到视野损伤量表的终点。
OAG患者较差眼每年典型恶化的估计值表明,其进展比一些基于临床的研究略快。进展率在种族或性别上无显著差异,但在已知接受治疗的OAG患者和人工晶状体植入患者中更差。